Detalhe da pesquisa
1.
Localized Immunomodulation with PD-L1 Results in Sustained Survival and Function of Allogeneic Islets without Chronic Immunosuppression.
J Immunol
; 204(10): 2840-2851, 2020 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32253240
2.
Pancreatic islets engineered with a FasL protein induce systemic tolerance at the induction phase that evolves into long-term graft-localized immune privilege.
Am J Transplant
; 20(5): 1285-1295, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31850658
3.
Local immunomodulation Fas ligand-engineered biomaterials achieves allogeneic islet graft acceptance.
Nat Mater
; 17(8): 732-739, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29867165
4.
Novel technologies to engineer graft for tolerance induction.
Curr Opin Organ Transplant
; 21(1): 74-80, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26626421
5.
Pancreatic islets engineered with SA-FasL protein establish robust localized tolerance by inducing regulatory T cells in mice.
J Immunol
; 187(11): 5901-9, 2011 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22068235
6.
Discovery of U2AF1 neoantigens in myeloid neoplasms.
J Immunother Cancer
; 11(12)2023 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38164756
7.
CBFB-MYH11 fusion neoantigen enables T cell recognition and killing of acute myeloid leukemia.
J Clin Invest
; 130(10): 5127-5141, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32831296
8.
Localized immune tolerance from FasL-functionalized PLG scaffolds.
Biomaterials
; 192: 271-281, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30458362